CAS 1365803-52-6

N-{2-[4-(but-2-yn-1-yloxy)benzenesulfonyl]-1-[4-(methanesulfonamidomethyl)phenyl]ethyl}-N-hydroxyformamide

CAS: 1365803-52-6

Fórmula: C₂₁H₂₄N₂O₇S₂

Pureza: ≥98%

Peso molecular: 480.5545

Ref: IN-DA01EIP1

KP-457

CAS: 1365803-52-6

KP-457

Pureza: ≥98%

Peso molecular: 480.56g/mol

Ref: 54-BUP05629

KP-457

CAS: 1365803-52-6

KP-457 is a ADAM17 and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).

Fórmula: C₂₁H₂₄N₂O₇S₂

Pureza: 98.33%

Cor e Forma: Solid

Peso molecular: 480.56

Ref: TM-T77778

N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide

Produto Controlado

CAS: 1365803-52-6

Fórmula: C₂₁H₂₄N₂O₇S₂

Cor e Forma: Neat

Peso molecular: 480.555

Ref: TR-B809708

N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide

CAS: 1365803-52-6

N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide is a synthetic, nonsteroidal drug product. It is metabolized by CYP3A4 and CYP2D6 to the active form. The N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide drug product has an analytical impurity of 4-[3-[(E)-[(E)-N′,N′′′-(dimethylamino)methylidene]-5′-(2′,5′-dioxoimidazolidinium)]bis[(Z)-formylhydrazono]]benz

Fórmula: C₂₁H₂₄N₂O₇S₂

Pureza: Min. 95%

Peso molecular: 480.6 g/mol

Ref: 3D-QEC80352